GENDOSE Trademark

Trademark Overview


On Monday, April 9, 2018, a trademark application was filed for GENDOSE with the United States Patent and Trademark Office. The USPTO has given the GENDOSE trademark a serial number of 87868947. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, September 17, 2024. This trademark is owned by GenDose Pharmaceuticals, LLC. The GENDOSE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, suppositories, allergy capsules and tablets, antihistamines, sedatives, laxatives, antacids, diet control remedies in the nature of diet capsules and diet pills, oral analgesics, vitamins and dietary supplements, capsule and nasal spray decongestants, medicated pre-moistened tissues, anti-nausea and anti-diarrheal remedies in the nature of nausea treatment preparations and diarrhea medication, diuretics, antihypertensive drugs, oral antibiotics, anti-anxiety drugs, anti-epileptic drugs, anti-inflammatory drugs, tranquilizers, vasodilators, anti-anginal drugs, anti-coagulants, anti-depressants, psychotropic drugs, anti-arrhythmic drugs, hormones, muscle relaxants, anti-convulsants, bronchodilators, cough and cold remedies in the nature of expectorants, drops, lozenges and syrups, medicated topical ointments and creams intended for the treatment of burns, dermatological use, antibiotics and eye infections
gendose

General Information


Serial Number87868947
Word MarkGENDOSE
Filing DateMonday, April 9, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, September 17, 2024
Registration Number5621398
Registration DateTuesday, December 4, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2018

Trademark Statements


Goods and Servicespharmaceutical preparations, namely, suppositories, allergy capsules and tablets, antihistamines, sedatives, laxatives, antacids, diet control remedies in the nature of diet capsules and diet pills, oral analgesics, vitamins and dietary supplements, capsule and nasal spray decongestants, medicated pre-moistened tissues, anti-nausea and anti-diarrheal remedies in the nature of nausea treatment preparations and diarrhea medication, diuretics, antihypertensive drugs, oral antibiotics, anti-anxiety drugs, anti-epileptic drugs, anti-inflammatory drugs, tranquilizers, vasodilators, anti-anginal drugs, anti-coagulants, anti-depressants, psychotropic drugs, anti-arrhythmic drugs, hormones, muscle relaxants, anti-convulsants, bronchodilators, cough and cold remedies in the nature of expectorants, drops, lozenges and syrups, medicated topical ointments and creams intended for the treatment of burns, dermatological use, antibiotics and eye infections

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 18, 2018
Primary Code005
First Use Anywhere DateThursday, May 5, 2016
First Use In Commerce DateWednesday, September 14, 2016

Trademark Owner History


Party NameGenDose Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCornelius, NC 28031

Party NameGenDose Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCornelius, NC 28031

Party NameGenDose Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCornelius, NC 28031

Trademark Events


Event DateEvent Description
Thursday, July 26, 2018ASSIGNED TO EXAMINER
Monday, July 30, 2018PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, April 12, 2018NEW APPLICATION ENTERED
Wednesday, April 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 2, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, August 2, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, August 2, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 18, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 2, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, August 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 13, 2018ASSIGNED TO LIE
Wednesday, August 29, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 4, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 8, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 17, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 17, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 17, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 4, 2018REGISTERED-PRINCIPAL REGISTER